Showing posts with label DVM. Show all posts
Showing posts with label DVM. Show all posts

Sunday, January 19, 2014

Pennsylvania Veterinary Medical Association- Compounding Drugs and Extra-Label Drug Use? Watch Your Step! Charlotte Lacroix, DVM, JD-February 8, 2014

Breakfast with the Expert

Special Feature! Earn 1 additional hour of CE credit.
Charlotte LacroixCharlotte Lacroix, DVM, JD

Compounding Drugs and Extra-Label Drug Use? Watch Your Step!
The contemporary practice of veterinary medicine presents unique difficulties concerning legal and ethical drug use in our patients. Compared to the introduction of human drugs, few new animal drugs come to market, and this has left veterinarians heavily dependent upon the use of human drugs for animals. The relatively short supply of approved animal drugs in convenient formulations has led to the widespread practice of drug “compounding." What is compounding? When is it the standard of practice? The ins and outs and appropriate use of FDA approved and compounded formulations will be discussed.

more information here

Wednesday, October 23, 2013

California: Compounded Medications and Veterinary Practice: Important Laws by Grant Miller, DVM, CVMA Director of Regulatory Affair September/October 2013


Many veterinary practices use compounded
medications in place of generic or legend brands in
their day-to-day operations. Compounded medications
refer to FDA-approved medications (generic or legend)
that have been altered to meet the needs of a particular
patient. FDA rules state that compounded medications
must be formulated directly from approved generic or
legend products, when such products are available. The
use of bulk products or raw active ingredients during the
compounding process is prohibited. Furthermore, if an
FDA-approved formulation of equal strength and form
exists, compounding of the product is prohibited.
Compounding pharmacies must carry current
licenses with the Board of Pharmacy in each state
where medications are compounded. In addition, the
compounding pharmacy must be registered in each state
to which it ships products. Therefore, if a practice uses
a compounding pharmacy in New Jersey, that pharmacy
must be registered with the California Board of Pharmacy.
To check the status of a pharmacy license with the
California Board of Pharmacy, visit: http://www.pharmacy.
ca.gov/online/verify_lic.shtml and select either “sterile
compounding” or “non-resident sterile compounding.”
While these rules are primarily applicable to the
compounding pharmacies, they do impact the veterinarian
because veterinarians are liable for medications used
or dispensed in their practice. Therefore, veterinary
practices that use compounded medications should
consult with the compounding pharmacy to determine
how the medications are being manufactured and
whether or not proper licensing exists.
In addition, should a practice regularly use
compounded products in their hospital stock, the
following California laws must be considered:
Compounding Defined
According to the California Code of Regulations, Title 16,
Section 1735(a): compounding means:
Altering the dosage form or delivery system of a drug
Altering the strength of a drug
Combining components or active ingredients
Preparing a drug product from chemicals or bulk
drug substances
Examples of compounding would include: making
a paste or oral suspension from crushed or melted
pills, or combining two injectable
medications in one vial or
syringe.
Compounding Exceptions
According to the same code listed above, compounding
does not include:
Reconstituting a drug pursuant to manufacturer’s
directions
Tablet splitting
Adding flavoring agents to enhance palatability
The 72-Hour Compounding Rule
It is unlawful for a practice to dispense compounded
medications to clients out of stock. The law states that
practitioners must provide a written or oral prescription
for a compounded product, to be filled by the client for
the animal patient. Therefore, while a veterinary practice
may use compounded medications for administration
in house, it must not send clients home with medication
from this stock.
One exception to this rule exists: the 72-hour
compounding rule. California Code of Regulations Title
16, Section 1735.2 (b) states that a practice may prepare
and store a limited quantity of a compounded product in
advance of a patient-specific prescription where such a
quantity is necessary to ensure continuity of care. The
law goes on to define a reasonable quantity as not more
than a 72-hour (i.e., three-day) supply, which is distributed
to a client upon patient discharge.
The 72-hour rule, which is enforced by the California
Veterinary Medical Board, is based on the scenario of
the Friday afternoon appointment. If a veterinarian sees
a patient on Friday at 4:30 and determines the need for
a compounded medication to suit that patient’s specific
needs, it may be impossible to obtain that medication until
Monday. Therefore, the law allows for a 72-hour supply
to be sent home with the client from the practice’s stock.
Veterinary practices may use compounded medications
in house, provided that the source that they are obtaining
the medications from is following FDA compounding
rules. If a practice dispenses a compounded medication,
the practice must observe the 72-hour limit on dispensed
medication and in turn provide clients with a prescription
to be filled at a compounding pharmacy once the three-
day supply is finished.
quoted from here

Thursday, June 27, 2013

Textbook for Vets Addresses Issues Relating to Compounded Drugs


Textbook of Veterinary Internal Medicine
By Stephen J. Ettinger, DVM, DACVIM and Edward C. Feldman, DVM, DACVIM
Chapter 160 – Compounding Drugs
Ron Johnson
One of the greatest challenges to veterinarians can be the availability of appropriate drug dosage forms that enable easier dosing of small dogs and cats and improve owner compliance. Although advances have been made with new drugs and dosage forms approved for veterinary medicine, clearly there is an unmet need with drug formulation options and dosages. As such, drugs approved in one animal species are frequently used in another species, including human-approved drugs. Compounded drugs can alleviate some of the drug-related issues facing veterinary medicine provided compounding is approached in a rational manner. There is little doubt that compounded drug formulations can offer effective and safe delivery options to veterinary patients. Support for this comes from the large number of pharmacies offering compounded drug products for veterinary patients and the increasing number of peer-reviewed journal articles that involve compounded veterinary …


UNDERSTANDING RISKS VERSUS BENEFITS WITH COMPOUNDED DRUGS
Pharmaceutical Issues
Compounding by medical professionals and pharmacists is not equivalent to the formulation of commercially manufactured products by reputable pharmaceutical firms. Drug formulation requires an understanding of the physical and chemical characteristics of the active pharmaceutical ingredient, along with the other agents (e.g., vehicles, excipients) used to produce the administered dosage form, in order to maintain the administered drug's effectiveness and safety profile. To this end, a compounded drug must possess adequate purity, potency, and demonstrate stability (shelf life) to maintain acceptable bioavailability (extent of systemic drug absorption) of the active pharmaceutical ingredient, but not produce toxicity or an ineffective preparation. However, for the vast majority of drugs compounded by veterinarians and most pharmacists, there is a lack of adequate pharmaceutical and clinical testing to ensure …

Transdermal Delivery of Drugs in Organogels
Transdermal administration of drugs for animals has the potential to be effective, safe, and can certainly enhance compliance. Absorption of drug via the transdermal route is primarily passive. As such, ideal molecules for this route of delivery are low molecular weight (<400 Daltons), lipophilic, and soluble in both water and oil.[10,11] Attention in veterinary medicine has focused on transdermal delivery of various drugs in organogels formulated for pulsed (single dose) therapy versus continuous release reservoirs (e.g., fentanyl patch (Duragesic).[12]
The growing list of drugs available in transdermal organogel formulations from compounding pharmacists includes antimicrobials, anticonvulsants, hormones, antineoplastics, prokinetic drugs, analgesics, and antiinflammatory agents. The vast majority of these compounded products are prepared in a pluronic lecithin organogel (PLO) vehicle. Lecithin is an emulsifying agent that forms a viscous gel when …
COMPOUNDING BY THE VETERINARIAN AND PHARMACIST: ROLES AND RESPONSIBILITIES
Compounding should be conducted in accordance with good pharmacy and compounding practices, relevant scientific literature, and applicable state laws. Pharmacy facilities used for compounding should have adequate room and equipment, be maintained in a clean and sanitary condition according to standard operating procedures in order to be effective, and prevent contaminations and errors. The USP 31-NF 26 contains a general chapter <1075> that addresses components of good compounding practices. These include responsibilities of the compounder, compounding facilities and equipment, recommendations for minimal training, and requirements for product packaging, labeling, and record keeping.[8]Importantly, there is now recognition of a separate veterinary compounding category by the USP-NF. The FDA Center for Drug Evaluation and Research has put forth a concept paper that evaluates drug products for human use that …
REFERENCES
1..  U.S. Code of Federal Regulations, Title 21—Food and Drugs: Part 530, Extralabel Drug Use in Animals, 1994.
2.. Center for Veterinary Medicine, US Food and Drug Administration Web site: Compounding of Drugs for Use in Animals.  Compliance Policy Guide. Ch 6 608.400. Available atAccessed August 2008 www.fda.gov/ora/compliance_ref/cpg/cpgvet/cpg608-400.html
3.. Geyer RE: Extralabel drug use and compounding in veterinary medicine. Food Drug Law J  1997; 52(3):291-295.
4.. Davidson G: The compounding controversy: what veterinarians should know to protect themselves and their patients. J Am Anim Hosp Assoc  2003; 39:13-17.
5.. Jordan DG: Pharmacist compounding vs veterinarian compounding: similarities and differences. J Am Vet Med Assoc  1994; 205(2):256-260.
6.. Riddell MG: AVMA's position on compounding for animals. Int J Pharm Comp  2005; 9(3):247-248.
7.. Papich MG: Drug compounding for veterinary patients. Am Assoc Pharm Sci  2005; 7(2):E281-E287.
8..  United States Pharmacopeia: Good compounding practices, The United States Pharmacopeia 31-National Formulary 26, Rockville, Md, 1075:500-503, 2008.
9..  United States Pharmacopeia: Pharmaceutical compounding-nonsterile preparations, The United States Pharmacopeia 31-National Formulary 26, Rockville, Md. 795:315-319, 2008.
10.. Marks SL: Transdermal therapeutics. J Am Anim Hosp Assoc  2003; 39:19-21.
11.. Riviere JE, Papich MG: Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev  2001; 50:175-203.
12.. Davidson G: Update on transdermals for animal patients. Int J Pharm Comp  2005; 9(3):178-182.
13.. Bennett N, Papich MG, Hoenig M, et al: Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats. Am J Vet Res  2005; 66:581-588.
14.. Hoffman SB, Yoder AR, Trepanier LA: Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther  2002; 25:189-193.
15.. Sartor LL, Trepanier LA, Kroll MM, et al: Efficacy and safety of transdermal methimazole in the treatment or cats with hyperthyroidism. J Vet Intern Med  2004; 18(5):651-655.
16.. Center for Drug Evaluation and Research, U.S. Food and Drug Administration: Drug Products That Present Demonstrable Difficulties for Compounding Because of Reasons of Safety or Effectiveness.  Rockville, Md, FDA Concept Paper, 2000.
17.. Davis J: Compounding for creatures: what works. Int J Pharm Comp  1999; 3(3):182-185.

source and to preview textbook click here




Saturday, February 23, 2013

35% of Veterinarians Say the Pharmacy Has Altered Their Prescription Print February 22, 2013 by Dr. Phil Zeltzman, DVM, DACVS, CVJ


Getting drugs at the pharmacy? Buyer beware.
Linda was terrified when her 8-year-old Lab had two seizures. She took Buddy to his family veterinarian, who diagnosed him with epilepsy. The treatment was phenobarbital (15 mg twice daily), a common anti-seizure medication.
Hoping to save money, Linda asked for a written prescription. Once she got to the pharmacy, the pharmacist remarked that the dosage was too high and recommended cutting it in half
Continue reading here